Polymeric Nanoparticles for Protonatable Nitrogen Therapeutics
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current nanoparticle delivery systems for protonatable nitrogen-containing therapeutic agents face challenges such as burst release profiles and poor drug loading, which limits their effectiveness in targeting specific tissues like cancer cells while minimizing harm to normal tissues.
Innovation Solution
The development of polymeric nanoparticles that incorporate a protonatable nitrogen-containing therapeutic agent, pamoic acid, and a diblock poly(lactic acid)-poly(ethylene glycol) copolymer, formed through an emulsification process with controlled pH quenching to create a hydrophobic ion pair, enhancing drug loading and controlled release properties.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Quantity of substance
If conventional nanoparticle delivery systems are used for protonatable nitrogen-containing therapeutic agents, then the nanoparticles can be formed and administered, but they exhibit burst release profiles and poor drug loading
Solution Approach 1:
The patent changes the pH parameter during nanoparticle formation and uses pH-responsive polymers that change conformation at different pH levels. The acidic pH during formation enables high drug loading, while the physiological pH transition triggers controlled sustained release, resolving the contradiction between drug loading quantity and release profile reliability
Solution Approach 2:
The patent employs composite nanoparticle systems combining pH-responsive polymers with protonatable nitrogen-containing therapeutic agents. This composite structure enables both high drug loading capacity and controlled sustained release profiles by leveraging the pH-dependent properties of the polymer matrix
2Quantity of substance
If the amount of drug associated with each nanoparticle is increased, then the therapeutic efficacy is improved, but the nanoparticle size increases which compromises delivery properties
Solution Approach 1:
The patent utilizes pH parameter changes during nanoparticle formation to maximize drug loading efficiency within a compact volume. The acidic conditions during formation allow high drug concentration incorporation, while the resulting nanoparticles maintain small sizes suitable for delivery, resolving the contradiction between drug quantity and nanoparticle volume
3Reliability
If targeted delivery to specific tissues is achieved, then the therapeutic effectiveness is improved, but the complexity of the delivery system increases
Solution Approach 1:
The patent imparts local pH-responsive quality to the nanoparticle system, where the polymer matrix exhibits pH-dependent conformational changes. This local property enables passive targeting through the pH gradient between tumor microenvironment and normal tissues, achieving targeting specificity without complex active targeting mechanisms
Solution Approach 2:
The nanoparticle system performs self-targeting through its inherent pH-responsive properties. The polymers automatically respond to pH changes in different physiological environments, enabling the system to self-regulate drug release and self-target tumor tissues without requiring external control or complex additional components
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The nanoparticles achieve improved drug loading and sustained release of therapeutic agents, reducing side effects and enhancing targeting specificity to diseased tissues, as evidenced by prolonged retention and controlled release profiles.
Implementation Method 1
the basic therapeutic agent and the acid form a hydrophobic ion pair prior to emulsifying the second phase
Implementation Method 2
quenching of the emulsion phase thereby forming a quenched phase
Data Source
AI summary
The present disclosure generally relates to nanoparticles comprising a substantially hydrophobic acid, a basic therapeutic agent having a protonatable nitrogen, and a polymer. Other aspects include methods of making and using such nanoparticles.